OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Transaction totals about $3 billion
The EQT X fund (EQT Private Equity), and Mubadala Investment Company have agreed to acquire Envirotainer—a provider of secure cold-chain solutions for the air transportation of pharmaceuticals—for approximately $3 billion. The deal is expected to close Q3 of this year.
The parties will seek to support Envirotainer in its next phase of growth by accelerating expansion in Asia-Pacific (APAC) and continuing growth in its other markets. They plan to help scale the newly launched CryoSure offering, while continuing the roll-out of the third-generation Releye platform.
“The temperature-controlled distribution of pharma products offers very attractive and thematic exposure to the fast-growing biopharma end-market,” says Ali Farahani, partner within EQT Private Equity’s advisory team. “Envirotainer is an integral part of the global pharmaceutical infrastructure … We continue to see significant growth potential ahead and are excited to partner with the management team to unlock the full potential together with our partners at Mubadala.”